Abstract The EU Horizon 2020 Framework-funded Standardized Treatment and Outcome
Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary …

Aim To identify the optimal STereotactic Arrhythmia Radioablation (STAR) strategy for
individual patients, cardiorespiratory motion of the target volume in combination with …

Background Options for patients with ventricular tachycardia (VT) refractory to antiarrhythmic
drugs and/or catheter ablation remain limited. Stereotactic radiotherapy has been described …

Purpose Cardiac radioablation (CR), a new treatment for cardiac arrhythmias such as
ventricular tachycardia and atrial fibrillation, has had promising clinical outcomes to date …

Background Single-session high-dose stereotactic radiotherapy (radiosurgery) is a new
treatment option for otherwise untreatable patients suffering from refractory ventricular …

Background Ventricular tachycardia (VT) is a potentially lethal complication of structural
heart disease. Despite optimal management, a subgroup of patients continue to suffer from …

Dose uncertainty induced by respiratory motion remains a major concern for treating
thoracic and abdominal lesions using particle beams. This Task Group report reviews the …

Background and purpose Several studies have suggested stereotactic arrhythmia
radioablation (STAR) as a treatment option for patients suffering from therapy-refractory …

Cardiac stereotactic body radiation therapy (cSBRT) is a non-invasive treatment modality
that has been recently reported as an effective treatment for ventricular arrhythmias …

The electrophysiology-guided noninvasive cardiac radioablation, also known as STAR
(stereotactic arrhythmia radioablation) is an emerging treatment method for persistent …